Document kmy1KnRONXmnbxO3BEyaEV47n

Goronel Laboratory for Occupational Medicine and Environmental Health, University of Amsterdam BIOLOGICAL CHARACTERISTICS OF THE EFFECT OF LEAD ON THE OBGANISM (Possible biological indices) INTSODUCTIOg In the last decades, industrial medicine has shifted away from a pure applied and descriptive discipline towards basic science research. Owing to the application of biochemistry, cytology, pharmacology, histochemistry, genetics and immunology, the field of stu dy in which industrial toxicology is engaged is considerably broadened. Less emphasis is being placed on the value of routine studies dealing with the evaluation of toxic effects of hazardous substances; on the contrary the importance is stressed of research, which aims at elucidating the toxic mode of action of these sub stances and in studying the pathogenesis of occupational dis eases. As a result of this modern concept, great advances have been scored in the knowledge of how toxic agents, foreign to the body actually act. The new insights that have been gained are based upon systematic observations, being the results of studies in va rious fields. It has to be realized however, that although these studies have clarified many problems, new ones have been opened up. Moreover, a great deal of uncertainty remains in the in terpretation of many findings and in the assessment of the re lationship between clinical symptoms and biochemical observations. Profound studies have revealed that the clinical manifestations, of toxic substances have their counterparts in injurious effects 3e) Acknowledgement: I am indebted to Prof.Zielhuis for the helpful discussion and critism in the preparation of the manuscript. N36937 at subcellular or biochemical level. Toxicants disrupt vital metabolic processes of cells or sub- cellular structures, consequently leading to functional impair ment of organs and to clinical symptoms. The interference with sub cellular processes is commonly accompanied by the presence of biochemical disorders. It is axiomatic that biochemical path ways may be impaired and these biochemical lesions occur whenever functional dysfunction in a tissue is apparent. The application of the concept of biochemical lesions has directed the attention of toxicologists to the development of screening methods, suitable for the early diagnosis of poisoning. The aim is to control the physical and chemical factors of the environmental air that con tribute to the development of chronic diseases. Since it has been recognised that toxic agents are capable of producing manifold lon^range, chronic, genetic or carcinogenic effects, research is focused on the understanding of biochemistry and pharmacology of these agents. This approach has deepened the study on possible metabolic derangements, that ultimately mif&t lead to subclinical effects. These derangements may have their own functional significance. Apart from the existence of specific damage to some target organ, studies in this field may reveal less obvious non-specific alter ations. Slight non-specific responses, as a compensatory activity of the body has been detected, following exercise of low levels of poisons. Chemical tests, based on this approach, may supplement classic methods of physical and hematological examination. They should not only be of importance in assessing and predicting the toxicity of a compound, but preferentially be capable to disclose disorders before the occurrence of pathological manifestations. Moreover the concern is to search for indicators (enzymes, me tabolites, etc.) whose alterations are in a certain relation to the exposure intensity and duration. Such alterations, frequently become apparent in the body fluids (blood, urine). It is the ela boration of tests on biological samples, which might be used to estimate the integral absorption and the proper magnitude of the exposure to which increasing importance is being attributed. From the viewpoint of possible swtabolic activities, lead has been shown to be involved in many processes. Contrary to previous DUP050313144 - 3- concepts the action of lead is now revealed to he far from simple. 1 The aim of this paper is to describe the close association which exists between the multiple biochemical lesions, provoked by the metal and the clinical picture resulting from these disorders. INFLpNCS=gi=LBAD=:0K_T!!=:HEMT0|01ESIS=AWD_0N=ERITHfi0C2TE| The study of lead toxicology has been dominated by the research es on the influence of the metal on the formation and degradation .'V.r,' : of hemoglobine and erythrocytes. The hematological disturbances, ,v " with resultant anemia, manifest in a condition of increased lead absorption or poisoning, actually has been the subject of numerous investigations. The emphasis that has been placed on this aspect of lead toxicity has two compelling reasons: the attempt to elu cidate the biochemical mechanism which lies at the basis of the toxic anemia produced by lead and the occurrence of pathological levels of some metabolites, related to the synthesis of hemoglo bine in case of increased lead intake. Since lead is capable of attacking the hematopoietic system in an early stage of exposure, tests on these metabolites in biological samples could be developed, which determine the pretoxic stage, and even could be elaborated into reliable parameters for the degree of exposure. These tests being of great value in the medical supervision of workers may be used in the practice as integral absorption indexes and render the possibility to follow up even slight responses of the organism. Although many papers have appeared, dealing with the genesis of lead anemia, the process whereby the metal induces this toxic phenomenon is by no means clear and there remains a great deal of uncertainty in the interpretation of the results. The older theory, which explains the anemia almost entirely to the hemolytic action of lead is no longer accepted. This action cannot be excluded in acute poisoning, but is in case of chronic poisoning of minor importance. Newer insights have been gained by experimental evidence, ex plaining the drop of hemoglobin by a profound inhibitory action of DUP050313145 lead on the metabolic chain of hemesynthesis (porphyrin distur bances). Biochemically, this disturbance implies that lead at tacks enzymes (or systems) at various points of the porphyrin synthetic chain. The defective hemoglobiniration is fundamental ly based on the profound effect on the blood-forming systems in the bone marrow cells exerted by the metal. Secondary to this effect are the changes observed in the peripheral blood, e.g. polychromasia, basophilia and reticulocytosis. Concerning the toxic action of lead on the hematopoiesis, three different aspects can be distinguished: a) the influence of lead on circulating erythrocytes b) the impairment of Hb-production, as a result of the injurious effeat of lead on bone marrow cells c) the stimulation of the erythropoiesis in the bone marrow. These features are all closely related to the manner in which lead is able to cause anemia. As yet it is impossible to give a satis factory picture of the background of lead anemia, which takes in to account the various experimental observations. In spite of the numerous investigations, it remains for more study to give an over-all embracing theory, which should cover and explain the mani fold experimental findings. The matter is complicated by the fact, that some of the experimental findings are apparently contradic tory. Furthermore it is generally agreed that there is no single factor which determines the genesis of the anemia. In the context of this paper, the views on the genesis of lead anemia can only be briefly outlined. The views related to the action of lead, are based on the ap pearance of the following biochemical events occurring in lead poisoning in vivo: urine - porphyrinuria; increased excretory output of coproporphyrine III (CP III) and to a lesser degree of type I - elevated excretion of 5-aminolevulinic acid (5-ALA) and of aminoacetone (AA) - slight rise of the urinary level of porphobilinogen (PBG) - increased excretion of iron (Fe). DUP050313146 - 5- blood a) serum: - increased contents of 5-ALA and of AA - increased Fe concentration, together with lowered Fe-binding capacity - increase of plasma porphyrins (protopjbrphyrin - PP IX and to a slight degree of CP's) b) mature erythrocytes of the peripheral bloodi - elevated level of PP XX - increase of non-hemoglobin Fe - decrease of Hb - reduction of the red bloodcell count (RBC) - decrease of Hb-synthesizing enzymes; 5-aminolevulinic dehy dratase (ALAD) and of heme synthetase - occurrence of punctate basophilia - siderocytes - reticulocytosis The erythrocytes are characterized moreover by increase of the osmotic resistance (O.R.), enhanced K+-outflow and shortened survival time. bonemarrow cells The occurrence of morphological entities, like basophilia, siderocytes, increase of erythroblasts and sometimes of megaloand macroblasts, and degenerative alterations of the mitochon dria with the presence of ferritin-molecules. tissue cells: accumulation of porphyrines in liver and kidney cells in some animalspecies in experimental poisoning. The importance of these phenomena in the clinical diagnosis of inallowahle lead absorption as well as their order of appearance will be described in connection with the three features of action of lead, mentioned on pag. 4. a. the influence of lead on circulating erythrocytes The assumption originally held by early investigators, that the anemia should be caused mainly by a direct influence of lead on peripheral blood red cells is in disagreement with most recent DUP050313147 - 6- observations. The older theory stated that the anemia is predo minantly hemolytic in character? the decrease of Hb should re sult from increased viability of the erythrocytes, terminating in elevated destruction-rate of these cells. Even, the porphyrin excretion in disease was considered to be derived from the acce- leration of Hb-breakdown . At present all evidence is in favor of the view that lead anemia arises mainly from enzymic blockage of the heme synthetic chain at various sites. Nevertheless, the adverse effect of lead-ions exerted on erythrocytes, both in vitro and in vivo, has been unequivocally demonstrated. Lead ions pos sess a great affinity to these corpuscles and especially to the cellular membrane. This interaction brings on both biochemical and physiological alterations. Morphologically, the cells, affect ed by lead ions undergo shrinkage; the cellular membrane is al tered which involves a net loss of osmotic active substances (K+) and water. Increase of the O.B. has been reported by several authors in experimental poisoning as well as in patients suffering from chronic disease2-5 . The findings, regarding the mechanical fragility of the red cells do not allow a definite conclusion whether this property is changed in lead poisoning. Leakage of K+-ions from the red blood cells, due to permeabili ty changes of the erythrocytary membrane, with resultant elevation of the plasmatic concentration of this cation, has been observed in vitro experiments in which lead salts were incubated with blood samples0" , as well as in lead workers''. The latter did not ex hibit obvious signs of toxicity, which leads to the conclusion that estimation of the K-ion concentration might be a valuable parameter of industrial lead exposure. It appears, that the loss of the cation is an event which occurs in an earlier stage of lead absorption than the alterations in respect to the physical properties (osmotic and mechanical fragility). It is likely that the erythrocytary membrane becomes early affected. Evidence for this view is provided in addition by the observation that the activity of the cation-dependent ATP-ase is diminished not sole ly in lead-poisoning but also before illness. Heavily exposed lead-workers, furthermore, showed a distinct reduction in the uptake of isotope-labeled phosphorous (32p) by the membrane^10' . This finding indicates that the P-metabolism, and particularly DUP05031 3148 -7- the incorporation rate of P32 into membranal phosphatidic acid is disturbed under the influence of small lead amounts. Contrarily to these membranal effects, the metabolism within the red cell corpuscles seems not to be severely affected in lead poisoning. The experiments indicate solely slight changes of the oxygen consumption and the glycolytic system. This, again suggests that the membrane has to be considered as the chief site of attack. The glucose consumption of erythrocytes, derived from lead workers is elevated in comparison with unexposed individuals, whereas the lactic acid production was insignificantly raised. This differences should be accounted to the relative abundance of young cells (reticulocytes) among the erythrocytes in the ex posed group. The elevation of the glucose consumption was shown to be correlated with the excretion of coproporphyrine12 . Finally, the existence of a shortened life span of erythro cytes in lead poisoning is a well-established fact. This phenomenon. may in some way be related to the'enhanced K -loss or alterna tively originate from the influence of lead on the bone marrow erythroblasts (disturbance of heme-synthesis). The experiments conducted with marked chromium (^ Cr) ~ or by using '?H-DFP , infer to an increased turnover rate of these isotopes, indicating decreased survival time. b. inhibition of heme biosynthesis by lead (mechanism) The chief site of production of hemoglobin (Hb) is in the ery- throblasts in the bone marrow. As mentioned previously, the anemia produced after the ingestion of lead is principally determined by the impairment of the biosynthesis of heme. This theory can give a satisfactory explanation, for the abnormal hematological picture and the abundant excretion of substances related to heme, in lead intoxication. All of the evidence is in favor of the view that lead exerts an inhibitory action on enzymes catalysing the various steps of the heme biosynthesis. Although the sites of attack of lead on the in vitro biosynthesis of heme now is rather well documented, the exact nature of the disturbance in vivo is virtually incomplete. The lack of knowledge can be ex plained by the fact that heme may he synthesised also in tissues either than the bone marrow, by the hypersynthesis of porphyrin DUP050313149 8- - precursors as an initial effect of lead and by the observation that the mode of action in vitro differs from that in vivo. A summary of the steps in the biosynthesis of porphyrin is given in the figure below. glycine + succinyl CO-A (active succinate) + pyridoxal phosphate CO 5-aminolevulinic acid (ALA) _vIE I' 3 porphobilinogen (PBG) 6h (light). UP I , T (2) UPGI h4 CO, CP I CPG I TT 6 H (light) pyrrylmethane UPG III 6 H (light) T , UP III (D cp CPG III CP III i <D ~i2 C0_ + 6 H (light) PPG IX |- >6 H PP IX le-r." NV Heme j<--globine hemoglobine Biosynthetic pathway of hemoglobine enzymes: ALA-syntveiase <g) ALA-dehydratase Q) PBG-deaminase <S) UPG-isomerase UPG-decarboxylase CPG-decarboxylase CD heme-synthetase abbreviations: UP : uroporphyrine UPG : uroporphyrinogen CP : coproporphyrine CPG : c oproporphyr ino gen PPG IX: protoporphyrinogen IX PP IX : protoporphyrine IX DUP050313150 Objection against the hemolysis-theory came first from Remington l8 1 197 who presented evidence that lead anemia arises from a blockage of the incorporation of divalent iron into the proto porphyrin molecule (hemesynthetase inhibition). This theory could explain the porphyrinuria, the elevated level of PP IX in ery throcytes and the deposition of iron in serum and bone marrow. Although the inhibition of heme synthetase is a well-established fact, observed by many researchers, it is assumed that this is not the only lead-sensitive step in the porphyrinic chain. Eriksen^' Dresel and Palk^' ^ presented evidence that lead interferes in the early stages of the pathway, e.g. before the synthesis of PBG. In vitro, the step catalysed by ALAD appeared to be extremely lead-sensitive. Similarly, strong inhibition of this enzyme was found in vivo-experiments by Goldberg et al2k Kreiner-Birnbaum and Grinstein25 investigated extensively the porphyrin and heme synthesis in lead poisoned rabbits by employ ing isotopically-tagged substrates (precursors). They concluded from their observations on the accumulation of the various inter mediates that the main blockage is at the level of ALAD. Secondly, the step catalysed by the enzyme (or enzymic system) UPG-decarboxylase most probably becomes inhibited, although to a lesser i ii extent. Using C-labeled CPG III as substrate, both PP IX and heme were found to be reduced in reticulocytes and hemolysates in the experimental animals. This is interpreted in a way that CPG-decarboxylaso is also blocked by lead, but conclusive direct evidence for this inhibition is lacking. Blockage of this step might provide an explanation for the rise of CP III, observed in the bone marrow cells, erythrocytes and blood plasma in experimental lead poisoning-(Sano ). In contradiction to heme-synthe tase, the other enzymes of the system-ALA synthetase and PBG de aminase - appear to remain unaffected in lead poisoning. With relation to the mitochondrial enzyme ALA-synthetase, this result was confirmed previously by Pecora2f? and Gajdos28 . It is postu lated that the enzyme inhibitions might be explained wholly by the high affinity of lead towards the essential sulphydryl groups (-SH) these enzymes possess. A full explanation on this basis is however unsatisfactory, since other metals with equal or even DUP050313151 10 higher* capacity to inhibit SH-groups do not disturb the in vivo synthesis.. For the depression of ALAD an indirect inhibitory ef fect due to accumulation of intermediates (PP IX) has been pro posed.. Detailed information on some of the enzymes and intermediates involved in the normal biosynthesis of heme is as yet incomplete known. This circumstance, in. addition, restricts the possibility of giving a complete and comprehensive picture of the enzymic in hibitions involved in lead poisoning. Stimulation of the erythropoietic activity The precise action of lead on heme synthesis is overshadowed by the observation that in beginning exposure, the blood-forming system is stimulated recognizable from a rise of the RBC together with increase of the Hb content. This effect is primarily expressed in the bone marrow. Rabbits exposed to 50 Mg Pb acetate/m showed an initial rise of Hb and the RBC, followed by a depression of these values after prolonged administration29 ,, The secondary changes in the peripheral blood, such as reticulocytosis and ba sophilia are manifestations of the increased response. In close association several authors emphasize the promotion of the synthesis of the porphyrins. Sano established that in lead poisoning the first disorder of the biosynthesis consists in hyper-synthesis of ALA, from glycine. The accumulation of PP IX is explained in a similar way. Italian authors confirmed this view, using several systems and observed an overactivity of the entire metabolic chain in vivo. According to Pecora^' ^ , the in vitro action of lead is quite different from taht in vivo: whereas in the first case the porphyrin formation is depressed, the reverse is true concerning the in vivo action at low concentrations of lead, ranging from 10-7 to 10-11 M. in the bone marrow. The sign of the effect in vivo is dose-dependent. If concentra tions of lead in the bone marrow reach 10 there is actually a depression of the synthesis. Additional evidence for the sti mulation is afforded by the fact that not only urinary CP III but also type I is elevated in lead workers in absolute magni tude'32, 33 DUP050313152 - 11 Other results also indicate unequivocally the capacity of lead to enhance the formation of porphyrins34 which appears to be contradictory to the ascertained blockage of the different en zymic steps. This divergency in results, again, illustrates the difficulties encountered in establishing the real mode of action of lead in vivo. Signilicancc and reliability of various parameters as indicators of elevated lead absorption a. basophilic stippled cells (BSC)^' ^ This phenomenon is manifested in the bone marrow cells and in the peripheral blood. In the marrow cells it occurs earlier and to a stronger degree than in the blood. In the latter, the enume ration of the BSC has been generally employed in workers to ob tain a valid index of response, because the appearance of any in crease precedes the depression of the Hb-content. There is how ever a wide divergency in results among the various authors, main ly due to diversity in methods. The reliability of the BSC largely depends on the counting and staining methods employed. The varia bility in results would bc much lower using one single standar dized technique. On this condition, there is a close relationship between increase of the BSC and the exposure intensity. The degree of stippling is related to the alterations of other parameters, and is paralel with the urinary levels of ALA, CP and lead. There is non-linearity between basophilia and the severity of the clini cal symptoms. Owing to its high specificity, the BSC is considered as a useful aid to follow up workers and a valuable supplement of other laboratory findings. b. reticulocytes35 ' 37 Eeticulocytosis is a very early occurring symptom. Owing to the greater aspecificity of this phenomenon, estimation of the number of reticulocytes is of lesser value than determination of the BSC. DUP050313153 12 - ,coproporphyria In the prevention of workers against inallowable lead absorp tion, the estimation of urinary CP has been proved to be of great value- In case of heavy exposure levels of CP may increase up to 10 to 30-fold of the normal concentrations. This phenomenon is an earlier response of the body than increase of the BSC, but has the disadvantage that it is less specific. Elevation of CP may result from a variety of other poisons and is present in certain 70 blood diseases'3 . A high degree of parallelism has been ascer tained between the intensification of the coproporphyrinuria and elevated levels of urinary and blood lead39--1+2 and urinary ALAii-3-46 by nany authors. Coproporphyrinuria on the other hand is unre lated to the occurrence of clinical signs of toxicity. Increased levels of CP III have also been found in mature erythrocytes47.' 48 , and in the bone marrow cells and kidney tissue49 of animals, experimentally poisoned. protoporphyrin (PP IX) Protoporphyrinemia is a phenomenon recorded by a vast number of investigators48 ' 50- 54 . The erythrocytary PP IX content is ele vated in a very early stage of lead exposure and may reach values 10 to 50r fold higher than in inexposed subjects. In addition, it is held a more specific reaction than coproporphyrinuria. Besides in plumbism, it is encountered in several other anemias, but does not arise from intoxicants other than lead. Noteworthy is the long persistance (a few years) of the phenomenon after cessation of the exposure53 . It is apparent that the measurement of red blood cell PP IX is one of the best indicators of disturbance of the hemato poiesis. Because of the fact that there is no simple analytical method available for determining PP IX, this parameter is less convenient for routine work. Elevation of free PP IX in the ery throcytes is related to the appearance of red fluorescence of these cells and visualized under U.V.light. According to Whitaker et al55 , the counting of the number of fluorescent cells might be helpful to diagnose lead poisoning. Additional research is needed to conclude whether this method is useful in the medical super vision of lead workers. Increase of plasma porphyrins in lead workers has been observed by Waldron^56 ; these substances consisted for the greater part of free PP IX. DUP050313154 - 13 - o. aminoketones (blood serum andurine) More recently, the attention is called to the value of urina ry ALA determination for early detection of increased lead absorption42-44*' 57 . Intensified ALA excretion has been shown in lead workers with or without toxic manifestations as well as in animal experiments. Since Mauzerall and Granick60 elaborated an excellent method for analyzing the concentration of ALA, deter mination of this parameter has been generally used in the control of occupational workers. Actually, the total amount of urinary aminoketones is determined by this method; from this ALA consti tutes a part, whereas the remainder consists chiefly of aminoace- tone (AA). There is however some divergency in results concerning Ji p the portion of total aminoketones which is represented by ALA 63 Owing to the extensive studies of Haeger-Aronssen42 on the use- fullness of ALA as laboratory test, the following conclusions can be drawn; - the increase in the urinary ALA varies directly with the degree of lead exposure; it implies a reliable indicator of the magni tude of the exposure; - highly significant correlation coefficients have been found in' lead workers between urinary ALA and lead (r = +0.92) (see also 64) and between ALA and CP (r = +0.69); - increased urinary output of ALA is a much more specific sign of hazardous lead absorption than abnormal CP levels; raised ALA levels have been found only in a few pathological conditions such as some types of porphyrins, in which the excretion of PBG is also strongly elevated however; - ALA is increased above normal at exposures in which CP does not exceed the normal limits, which supports the view that it is a very sensitive and-early parameter^' - in case of heavy exposure, urinary ALA levels may reach values higher than 30-times the normal concentrations (about equally as for CP). These features have been confirmed by many of the mentioned authors. A certain paralelism became apparent between the magni tude of ALA increase and the appearance of toxic signs. ALA de termination has been proved to be suitable to define the quantity of metabolically active lead in the organism, and was highly cor- DUP050313155 14 related with blood lead values (r = +0*90) Similarly, a rather high correlation was established between the elevations of free PP IX in the red blood cells^ or the BSC^ and those of ALA. The intensification of the ALA-excretion is in agreement with the proposed enhancement of porphyrin synthesis induced by lead. This results in increased production of the metabolite. Because of the blockage of ALAD, the compound cannot go through further stages of the metabolic chain. Consequently, the blood level of ALA is raised with either overflow of the metabolite into the urine or alternatively decreased reabsorption of ALA in the renal tubules. In agreement with this view, Saita et al observed in persons ffected by lead an extra-increased excretion of ALA (and increased blood level) after administration of glycine per os, in comparison with unexposed individuals. Elevation of urinary aminoacetone (AA) has also been observed in lead workers: the ex tent at which this metabolite is increased is however less than is the case of ALA69 . Clarification of the abnormal AA metabolism awaits further research however. Significant elevations of ALA in serum have been shown to accom- pany consistently those of the urinary ALA levels^ ' ' ' .A direct propostionality has been detected between both concentra tions. Some evidence has been presented that serum ALA elevation even precedes the augmentation of urinary ALA. As biological ex posure test, the determination in serum is less suitable, since the extent of the increase is less than for ALA in urine and the normal levels are too low to measure with great accuracy. f. iron-metabolism The disturbance of the Fe-metabolism may be explained in terms of the impairment of the heme synthesis. Blockage of heme synthe tase results in a diminished utilization of iron. This is mani fested in the occurrence of iron-stainable inclusions in the red cells (siderocytes^) and in the erythroblasts (sideroblasts) in patients and in experimental animals. These corpuscles contain molecules of ferritin inside the mitochondria and vacuoles, ac cording to electro microscopic observations. DUP050313156 - 15 - Hypersideremia (increase of Fe in theserum), together with a decrease of the latent binding capacity resulting in a raised saturation percentage, is a common phenomenon encountered in poisoned subjects and experimental animals by several authors'"~ There is no evidence that serum Fe contents are altered in ex posed workers without signs of intoxication. Zegarski established 8-1 a certain correlation between this parameter and urinary CP Studies on the urinary excretion of Fe revealed, that the metal may be increased in lead workers, without any signs of toxicity. The extent of the alteration was related to the duration of the exposure 82 Much work has been done to elucidate the complex manner in which Fe-metabolism becomes disturbed by lead. Discussion of the various findings with respect to this disorder, is however beyond the scope of this paper. g. inhibition of ALAD Crude preparations of the enzym, located in the erythrocytes, are inhibited by certain heavy metals and SH-group inactivating substances83 ' 8^ .In vivo, ALAD-activity was shown to be suppressed both in rabbits subjected to lead poisoning 86 and in human plumbism87-90 . Experiments performed on animals by means of i.v. or s.c. injections of lead salts demonstrate that the enzym inhi bition occurs at extremely low levels, viz at dose levels too low to cause any change in the urinary Pb, CP or ALA levels . Confirmation of this early response of the body has been obtained by assaying ALAD activity of lead workers90 . Activities below normal were recorded in subjects with a very slight degree of exposure. In these cases the other urinary parameters remained unchanged. Hence, it is concluded that the blockage of ALAD may be considered as the most early and sensitive sign of increased n lead absorption (at about 10 M). Similarly, in the rabbits ex periments inhibition of ALAD preceded the appearance of copropor phyrinuria. In these studies, a marked dose-dependent relation ship has been established(amount of lead injected versus degree of inhibition). In groups of occupational workers, a fairly close linear relationship existed between urinary lead, CP or ALA and the reciprocal enzyme values. This strongly strengthens the va DUP050313157 - 16 - lidity of ALAD activity as exposure test. However, the fact that this enzyme is influenced in such a sensitive and early way might limit its usefulness in preventing poisoning. Because of the low activities already observed in moderate exposure, difficulties would be encountered in discriminating real lead poisoning from stages with low exposure degree. Nevertheless, the studies are. valuable in demonstrating that lead can bring on an effect on the organism by intake at minimal doses. h. heme synthetase As pointed out already, the inhibition of the altimate step of heme synthesis has been claimed to constitute an important factor in determining impaired porphyrin metabolism. Experiments show that lead-ions exercise a strong blocking ac~ tion on the enzym at about 10-4M; below this level the degree of inhibition decreases, parallelwith decreasing concentration197' 22 ' 2.b. In vitro investigations performed on red blood cells of rabbits, ducks and humans demonstrate that at 2.10 J and 4.10 the in- fluence is neglectible 92 ' 93 . Heme synthetase was measured by following the rate of Fe 59 incorporation into heme. In vivo, the inhibition of heme synthetase was shown in patients with toxic signs and in prolonged experimental poisoning94 . According to Otrzonsek 95 , heme synthetase is reduced in the bone marrow cells, but increased in hepatic tissue. Apparently, the liver is capa ble to take over part of the Hb synthesis from the bone marrow. Little work is done, up to now, on the possible reliability of this enzyme as early parameter. DUP050313158 17 - Bibliography 1. Kench J.E.; Lane K.E.$ Varley H. BritoJ.Ind.Med. ,9(1952)133 2. Aub J.C.; Beznikoff P. J.Exp.Med. 40(1924)189 3 Rubino G.F.5 Prato V.5 Fiorina L. Folia Med. 39(1956)1117 : 4. Fratianne R.B. ; Griggs R.C.; Harris J.W. Clin.Res. (1959)384 5. Griggs R.C. Progr.Hematol. 4(1964)117 6. Joyce CTR.B.5 Moore H.A.; Weatherall M. Brit.J.Pharmacol. 9(1954)463 7 Grigarzik H.| Passow H. Pflug.Arch. Ges.Physiol. 267(1958)73 8. Passow H.; Bothstein A.5 Clarkson T.W. Pharmacol.Rev. 13(1961) 185 9. Hasan J. 5 Hernberg S.; Metsala P.; Vihko V. Arch.Env.Hlth. ,4(1967)309 10. Westerman H.P.; Jensen N. J.Clin.Invest. 42(1963)991 11. Rozenberg P,,A.$ Smirnova M.I.; Gig.Trud.Prof.Zabol. 5,(1961)35 12. Hasan J.; Hernberg S. Work-environment-health. Vol.2:, no.l/1966, p.38 Inst.Occ.Hlth. Helsinki 13. Leitkin S.; Eng G. Pediatrics 31(1963)996 14. Rubino F.G. ; Prato V.; Fiorina L. Folia Med.42(1959)1 15. Combrisson A,,; Desoille H.; Albahary G. Proc.l4th Int.Congr. Occ.Hlth Madrid 1963, 11, 755 16. Sroczynski J.5 Jonderkf. G. 3 Watras J.; Int.Arch.Gew.Path.Gew. Hyg. 21(1965)223 17. Hernberg S.; Wurminen M.; Hasan J.; Int.Arch.Gew.Path.Gew.Hyg. 23(1967)117 18. Bimington C. Acta Med.Scand. 143(1952)l6l 19. Bimington C. Brit.Med.J. (1956)189 20. Eriksen L.; Scand.J.Clin.Lab.Invest. 4(1952)55 21. Eriksen L.; Scand.J.Clin.Lab.Invest. 7(1955)80 22. Dresel E.I.B.5 Falk J.E.; Bioch.J. 63(l956a)72 DUP050313159 - 18 - 23. Dresel E.I.B.; Falk J.E. Bxoch.J. 63(1956b)80 24. Goldberg A.; Ashenbrucker H.; Cartwright G.E.; Wintrobe M.M. Blood 11(1956)821 23. Kreiner-Birnbaum M. $ Grinstein M. Biochira. Biophys. Acta rn( 1965) 110 26. Sano S. Acta Haemat. Jap. Suppl. 21(1958)337 27. Pecora L.; Pesaresi L.; Lamanna P. Folia Med. 47(196*0985 280 Gajdos A.; Gajdos-Torok M. Bev.Franc.Et.Clin.Biol. 9 (1964)629 29. Goltblatt M.W.; Goltblatt J.; Merewether E.H.A. Industrial Medecine and Hygiene dl.III, 1956 30. Pecora L. Med.Lav. 53(1962)29 31. Pecora L.; Fati S.; Mole R.; Pesaresi C. Folia Med. 48(1965) 33 32. Kench J.E.; Lane B.E. ; Varley-Brit-. J.Ind.Med. _9(1952)133 33. Mehani S. Brit.J.Ind.Med. 23(1966)112 34. CaccH'-i S.; Pecora L.; Fati S.; Vecchione C. Arch.Mai.Prof. 22(1958)341 35. Cantarow A.; Trumper M. Lead poisoning (1944) 36. Lane B.E. Brit.J.Ind.Med. 6(1949)125 37. Baikie A.G.; Valtis D.J. Brit.J.Exp.Path. 350954)434 38. Watson C.J.; Larson E.A. Oxford Loose Leaf IV(1951)228 39. Stankovic M.; Poleti D.; Petrovic L. 13th Int.Congr.Occ. Hlth. N.Y.1960, 368 40. Shiels D.O. Med.J.Austr. 2(1953)171 41. Chisholm J.J.; Harrison H.E. J.Clin.Invest. 35(1956)1131 42. Haeger-Aronsen B. Scand.J.Clin.Lab.Invest. _1_2 Suppl.47, I960 43. Gattner H.; Schrantz G. Dtsch.Med.Wschr. 89 0 964) 1027 44. Kretser A.J.de; Waldron H.A. Brit.J.Ind.Med. 20(1963)35 45. Cramer K.5 Selander S. Brit.J.Ind.Med. 22 (1965)311 46. Djuric D.; Novak L.; Milic S.; Kalic-Filipovic D. Med.Lav. 57 0 966)161 DUP050313160 19 - 47. Schmid R.; Schwarz S.; Watson C.J. Proc.Soc.Exp,Biol.Med. 5 (1950)705 48. Rubino G.F.; Rasetti L.; Teso G.A. 13th Int.Congr.Occ.Hlth N.T. I960 49. Suzuki T.; Suzuki S. Ind.Hlth. 4(1966)56 50. Vigliani E.C.; Angeleri C. Clin.Med.Ital. 66(1935)5 51. Watson C.J. A.M.A. Arch.Ind.Med. 86(1950)297 52. Bashour F.A. Centre Soc.Clin.Res. 44(1955)764 53. Rubino G.F. ; Pagliardi E.; Prato V. | Giangrandi E. Brit.J. Haematol. _4( 1958) 103 54. Sano S.; Inone S.; Harada A.; Oriza Z. Acta Scholae Med. Univ.Kioto 36(1960)182 55. Whitaker J.A.5 Vietti T.J. Pediatrics 24(1959)734 56. Waldron H.A. Brit.J.Ind.Med. 21(1964)315 57. Holmqvist I. Schr.Ges.Dtsch.Metalhiitten- und Bergleute 7(1960)115 58. Griggs R.C.; Harris J.W. Clin.Res. J$(1958)l88 59. Tishkoff G.H.5 Granville H.B.; Rosen R.; Dameshek W. Acta Haematol. (Basel) (1958)321 60. Mauzerall D.; Granick S. J.Biol.Chem. 219(1956)435 61. Prato V.; Ramello A,,; Mazza 13. Minerva Med. 54(1963)853 62. Meo G.; Martoranno G.; Bonzanino A.; Perrelli G. Boll.Soc. Ital.Biol.Sper. 40(1964)649 63. Pisani Bonzanino A.; Lacquaniti A.; Med.Lav. 58(1967)279 64. Singerman A. Arch.Env.Hlth (1964)464 65. Buckup H.; Mappes R. Zentr.hl.Arb.Med. Arb.Sch.12(1962)293 66. Albahary C. Arch.Mai.Prof. 25(1964)495 67. Sroozynski J.; Hrbanowicz H. Arch.Mai.Prof. 12(1964)487 68. Saita G.5 Moreo L.; Levizzani G. Med.Lav. 58(1967)364 69. Waldron H.A. J.Clin.Pathol. 18(1965)230 DUP050313161 20 70. Rasetti I>.; Parigi A. Folia Med.. 45 ( 1962)480 71= Saita G=; Moreo L. Med.Lav. !54(1963)183 72= Chiesura P.; Brugnone F= Med.Lav,. 54(1963)88 73= Saita G.; Moreo L. Med=Lav= 55(1964)337 74= Balho W=; Gualdi G,,; Maruoci V. Folia Med= 48(1965)554 75- Druyan R.; Haeger-Aronsen B-; v.Studnitz W=; Waldenstrom J. Blood 26(1965)181 76. McFadzefira A.J.S.; Davis L.J. Quart.J.Med. 18(1949)57 77= Vanotti A-; Imholz A. Z.Gee.Exptl.Hed. 106(1939)597 78= Graziani G; Fusco M=5 Rossi L= Folia Med. 37(1954)657 79= Saita G=; Moreo L; Petrocchi V- Med.Lav. _1_(l955)46 80= Graziani G=; Calatoro F= Proc.12th Int.Congr.Occ.Hlth. 11(1957)52 81. Zegarski W. Acta biol.Med.Soc.Sci= Gedan 1(1963)53 82= Orlando E=; Raffi G.B=; Alessandri M. Med.Lav. 56(1965)732 83= Gibson K.D.; Neuberger A.; Scott <J.J= Biochem.J. 61(1955)618 84= Granick S. j Mauzerall D= J.Biol.Chem. 232(1958)1119 85. Bonsignore D.; Calissano P=; Cartasegna C. Bollet.Soc.Ital. Biol.Sper. 41(1965)443 86. Bonsignore D.; Cartasegna C. Lav.Umano 18(1966)529 87= Lichtman H.C.; Feldman F= J.Clin.Invest. 42(1965)830 88= Rubino G.F. Panminerva Med. 4(1962)7 89. Bonsignore D=- Calissano P.; Cartasegna C. 199 Med.Lav.56(1965) 90. Bruin A.de; Hoolboom H. Brit.J.Ind.Med. 24(1967)203 91= Bruin A.de; Med.Lav.; submitted for publication 92. Klein J.R. Amer.J.Physiol. 203(1962)971 93= GajdoE-Torok M.; Gajdos A.; Benard H. C.R.Soc.Biol.154(i960) 508 94. Boyett J.D.; Butterworth C.E. Amer.J.Med. 52(1962)884 95= Otrzonsek W. Int.Arch..Gew.Path.Gew.Hyg. 24(1967)66 DUP050313162 21 MISCELLANEOUS BIOCHEMICAL ASPECTS a cftzyrce activities The literature, dealing with studies concerning changes of enzyme activities as a result of the influence of toxic sub stances is steadily growing. Regarding lead two features should be distinguished from each other: elevation of certain enzyme activities in the blood plasma as an expression of some tissue damage caused by absorbed lead and secondly the inhibitory action of lead on the activity of enzymes, localized in the tissuesCorgans) and present in the blood serum, resulting in a lowering of these activities. Study on the enzyme changes may be helpful in clarifying the toxic mode of action of lead. It is tentatively suggested furthermore that the quantitative assay on enzymes would hold a biochemical rationale useful for the assessment of the degree of poisoning, or even might be of value for control ling the exposure of lead workers. Several reports have been devoted to the estimation of serum enzyme activities such as the transaminases (SGOT, SGPT), aldo lase (ALD), alkaline phosphatase (alk.Ph.), pseudo-cholinesterase (p-ChE) a.s.o. in case of occupational and experimental lead poisoning. Pathological increased levels of both transaminases have been encountered by some of the investigators in lead poisoned work- 1-3 ers . Contradictory results, however, were obtained by several 4-7 other authors . In healthy workers, without any clinical picture, the absence of a rise of these enzymes seems well-established. Experimental poisoning resulted in an average three-fold increase g of serum transaminase activity . The final conclusion may be, that these serum enzymes could reach values above normal in cer tain circumstances of lead poisoning, most probably as resulting from hepatic disturbance. The ALD-level is found to be increased, both in patients 5 suspected of plumbism and in healthy individuals, occupational- g ly exposed to the metal . A good correlation was found between this enzyme level and the urinary excretion of lead. Hence, esti mation of ALD-activity might be considered as a valuable diagnostic procedure to control workers and to prevent them from poisoning. DUP050313163 22 '< The behaviour of alk.Ph has been the subject of extensive studies of Kosmider 10 ' 11 . He established a strong decrease of the en zyme level in animals, acutely intoxicated as well as in lead workers with signs of toxicity. In the former case, the degree ^...ViOf lowering of alk.Ph-activity rans paralel to the experimental \ dose. Moreover, a close relationship between the decrease of the enzyme activity, and changes of other parameters was established (CP, serum protein changes). The biochemical derangement, which . .'. underlies this action of lead is presumably connected with the 'I, '1''inactivating influence of the metal on functional groups of the enzyme, essential for integral enzyme activity (-SH and/or C00H..' .# t.l..groups), although the possibility that lead is capable to com- 'pete successfully with the activating magnesium-ions cannot be excluded. Differences in the raising or lowering of bloodenzyme activities include other enzymes than those mentioned. Thus, p-ChE activity consistently is below normal in patients suffering from chronic lead overexposure 12 ; a finding which could be con firmed in experimental induced poisoning. A negative correlation was found between these decreased values and the blood lead con- " centrations. Enhancement of the activity of catalase 12 and depression of carbonic anhydrase 13 has been shown to occur in case of human and animal lead absorption; the decrease being in some relationship with the physical condition of the workers. The de pressing enzyme activity was more pronounced with increasing dis position. Both enzymes appear to be sensitive to the action of heavy metals and oxidizing agents. Some other enzymes, involved in the carbohydrate and energetic metabolism, are affected in case of lead poisoning, but only to a slight degree. The significance of enzyme changes has been up to now incompletely established. It should be considered that the alterations might indicate not merely a toxic response of the body to the action of the metal, but apart from this may be the expression of adaptive changes of the body; in other words they could be the provoked reaction of the organism to adjust the non-specific stress exerted by the toxicant. Apparent disturbances would then be absent. Further research is necessary to elaborate these non-specific changes to tests, potentially capable of discriminating workers showing clinical symptoms and those who do not exhibit these mani festations. DUP050313164 - 23 - In views of the action of heavy metals on the erythrocytes, the attention has been focused on the study of erythrocytary en zymes following in vivo lead salt intake. Extensive reference has been made on the enzyme ALA-dehydratase. Except for this enzyme, more significant enzyme deviations from normal within the red cells could be observed in lead poisoning. The studies comprise mainly the enzymes, involved in the glycolytic breakdown of sub strates. The slight elevations found in certain circumstances should be ascribed to the acceleration of the hematopoiesis ob served initially in lead poisoning. It seems that the penetrative capacity of the metalions is very small. It has to be considered, however, that lead-ions are accumulated in the surface of the erythrocytary membrane 14 , thus interacting with biochemical processes, which regulate the transport of metabolic ions across the cellular membrane (K , Na ). Functionally coupled with this process is the activity of the enzyme (Na+ + K+)ATPase, localized in the red cell membrane. The enzyme, which catalyses the hydrolysis of ATP supplies the energy, necessary to keep functioning the so-called cation pump. The pump exchanges ions (K+) against the concentra tion gradient, thus maintaining a high concentration of K+-ions within the red cells. Hasan et al 15 16 studied the behaviour of the enzyme in the membranal fragments of 40 occupationally exposed lead workers, free from clinical symptoms and demonstrated that the enzyme was diminished in activity (average: 30$) in comparison with a normal unexposed group. Although any correlationship between the dimination of enzyme activity and the alterations of other blood para meters, seems to be absent, the result indicates that estimation of the cation-depended enzyme may be used as a predictive test of excess lead absorption'. Histochemistry Histochemical methods have recently opened new approaches to the study of the nature of the toxic effects of poisons exerted on tissues and particular organs. New staining methods have been successfully employed to investigate subtle alterations regarding chemical constituents and enzyme activities at cellular level. DUP050313165 - 2*1- - Experimental studies of this kind in lead toxicology have re vealed the multiple picture of toxic manifestations, produced by the metal. Summing up briefly the results; histoenzymatical alterations were detected in both the heart and skeletal muscle, small blood vessels, liver, kidney, intestines, and the salivary gland . The studies include enzymes such as WADH-diaPhoraoe cytochrome oxidase, succinate dehydrogenase, ATPase, alk.Ph., and carbohydrate splitting enzymes. The data obtained indicate that lead is enable to suppress cellular oxidation-reduction pro cesses and to inhibit the active transport of energy-supplying organic phosphates (ATP) in the muscles. These changes have been discussed by the authors in relation to clinical signs of toxici ty. Although these techniques hold very practical tools to design the functional impairment provoked by the toxicant, they do not serve as a guide for assessment of the exposure degree in occu pational conditions. b. modification of the blood serum protein pattern As is evident from electrophoretic studies, excessive lead- absorption may result in changes in the composition of the serum proteins. The data obtained concern almost exclusively lead workers, with a certain clinical picture of poisoning, in which the observed deviations from the normal composition are the largest 22--29 . People, with long contact to lead, but without signs of toxicity only show minor changes of the serumprotein composi tion. In chronic poisoning, the alterations are more pronounced ac cording as the severity of the clinical symptoms aggravates. The studies reveal, generally, a decrease of the A/G ratio of the serumproteins, as the most common deviation from normal. The albumin^ is reduced and the globulin fractions are corres pondingly increased. Especially, the and p-globulin contents are most markedly influenced, whereas the Y-globulin fraction fluctuates in a variable manner. Similar alterations were observed by inducing lead intoxication into animals, both acutely and chronically"3^0 1 3J*1 . Several DUP050313166 - 25 - investigations assume that serum electropheris might he a'va luable technique in the detection of early stages of lead intoxi cation. Shifts in the serum protein composition have been manifested only seldom in subjects, without clinical symptoms. Hence, it may be concluded that the method is not useful as a pretoxic test of increased lead absorption. The basis for the interpretation of the observed dysproteinemia, provoked by the metal and its salts may be the affection of the liver. Lead, like other heavy metals is capable of dis turbing the function of the liver and to bring on parenchymal damage. The involvement of the reticulo-endothelial system of the bone marrow may be regarded as an additional causative fac tor, however. c. the urinary aminoacid pattern Apart from the abundant excretion of ALA in the urine, lead may provoke an hyperexcretion of some aminoacids. Some authors reported the existence of an abnormal urinary aminoacid profile 32-34 in case of accidental lead poisoning - particularly in childhood - as well as in experimental poisoning. In these chro matographic studies, the strongly increased excretion of alanine and of glycine was predominant. It is generally accepted that this phenomenon is closely associated with the renal disturbances observed in lead poisoning. There is up to now not a consensus of opinion regarding the exact type of nephropathy produced by lead and its significance in chronic occupational exposure. As is evident from clearpnce-values the type of renal dysfunction depends more or less on the exposure duration and intensity. The injury is found frequently to be transitory and functional in character. Won-reversible kidney changes have only been observed in a few cases with prolonged and intensified contact with the metal. Whenever the kidney function is impaired and particularly if the reabsorption mf the proxional tubular cells is disturbed, the abnormal excretion of aminoacids may be a reflectance of this phenomenon. In view of the above findings, determination of DUP050313167 - 26 - the urinary aminoacids may however not regarded as to be of diagnostic value in lead poisoning. d. metal shifts in lead poisoning Displacement of essential metals is considered as a general biological indicator of toxic response. Industrial exposure to various toxicants may result in characteristic shifts in mineral content of animal organs and blood, as has been evidenced for carboiQdisulfide, vanadium and beryllium. Similar phenomena have been encountered in subjects affected by lead poisoning or in workers being in long-term contact with the metal but without toxic manifestations otherwise. Besides the profound effect of lead on the iron metabolism, the observations include abnormally high serum zinc and copper quantities37 1 38 . The significance of these findings in relation to the development of clinical symptoms is still unexplained. Likewise, the role these changes play as possible prognostic indicators of immanent intoxication, needs further research. The derangements regarding metal metabolism might be connected with the competitive action of lead in metallo- enzymee, in which these cations are of importance. ..T..h..e. strong . .. elevation of copper in the red cells of lead patients may be furthermore brought into relation with the deficient hemoglobini- Dysregularities have been reported, in addition, concerning the metabolism of the alkalimetals calcium and phosphate40-43 . It has been established that the serum levels of calcium and of potassium are elevated in animal poisoning, whereas that of so dium is depressed. These elevations paraleled the increase of the lead concentration in "the blood, and might therefore be of value in estimating the degree of exposure. Further emphasis has to be placed upon the study of the cations in the blood of lead workers to investigate whether there exists some relationship between the blood-concentration of lead and the other metals. It is suggested that the elevation of calcium in the serum has to be attributed to the mobilizing action of lead on the calcium of the skeleton. The increase of plasmatic potassium is undoubtedly by the reflec tance of the potassium-loss through the erythrocytary membrane, induced by excessive lead absorption. DUP050313168 - 27 - !ei., urinary excretion of steroids The functional condition of the adrenal cortex is known to he altered under the influence of small amounts of toxic chemicals, Vnu'i'.t .v.v;vizlead. Measurement of the urinary values for 17-hydroxycorti- colds and 17-ketosteroids is regarded a diagnostic tool in de- tecting adrenal dysfunction. Based upon this fact it may he the . , . speculated, whether analysis of the urinary steroids in lead ii.ii workers might provide reliable indication of the exposure degree . '''. .'Vy.'........ iV' So far, the data obtained refer solely to animal experiments. The , ; influence on the adrenals appear to be dependent on stage and in- tensity of exposure. In the early stages decreased levels of uri! 1 > ' f *. , . nary steroids were noted, whereas m case of heavy exposure and .'v i:"/ ',;/. . in'advanced poisoning the excretion was augmentedk5 . : r 1; f. action on the iodine metabolism A few reports on animals indicate that lead exerts a depres sant effect on the thyroid gland, as measured by the rate of up- i3i 46 take of marked iodine ( I) by the gland The lowered level for protein (hormonal) bound iodine (PBI) in blood, found in sheep following chronic lead poisoning is in : k-7 , agreement with the hypoactive state of the gland mentioned above . Up to now, no data have been gathered on the iodine metabolism ' in subjects from lead-processing industries; in view of the ear- ' : ly response toxic substances on the thyroid and other glands on toxic substances, evaluation of the iodine metabolism might con- ;'y' stitute reliable means for the estimation of the early diagnosis ' of lead poisoning. g. blood coagulation Altered blood coagulation has been observed in a variety of industrial intoxications. A decreased clotting tendency results k8 from the protracted influence of lead , which according to 49 Saita has to be attributed to deficiency of one of the thromboplastic factors (factor VII) as well as to a slowing down of the prothrombin synthesis in the liver itself. These phenomena are DUP0503131 69 - 28 - likely to be explained by assuming an impairment of the synthe tic potency of the liver. The thromboelastographic technique al lows the possibility of differentiating between the various modes of action, according to which toxicants influences the clotting mechanism, and affords a diagnostic means to detect slight changes of the coagulation. h. action of lead on active chemical groups It has been stressed upon that lead acts on several functional groups. The affinity of lead for the sulfhydrylgroup (-SH) con stitutes without doubt an essential feature of certain enzyme in hibitions produced by the metal. Consequently, various metabolic processes can be disturbed in lead intoxication. The body, on the other hand, possess a natural defence mechanism to overcome these biochemical lesions. This is provided by the presence of free thiol groups in the blood and tissues (glutathione). Both in vi tro and in vivo experiments, it has been ascertained that lead provokes a lowering of the glutathione content of erythrocytes^' . The total amount of free thiol groups, appeared to be reduced m the sera of group of workers, even without clinical symptoms52 . It is suggested therefore that determination of glutathione and/or the content of free-SH-groups could have some value as a diagnos tic pretoxic tests in the medical prevention of lead poisoning. Likewise, recourse can be made to the estimation of the con centration of the blood a-aminonitrogen content, which may be indicative of the affinity of lead to vulnerable chemical groups55 . Related to the action of lead on thiol groups, is the appea rance of Heine bodies, whose formation is due to the oxidation of thiol groups, which are bound to the globin moiety of the hemoglobin molecule. According to Ghelherg et al 5k , children living in the neighbourhood of lead-processing industries presented a higher proportion of Heinz bodies in their blood than children, inhabiting rural environments. It is of importance to investi gate, whether this is also the case in industrial lead workers. DUP050313170 - 29 i. immunologic response There is much evidence that toxic substances have adverse influences on the available immunity mechanisms of the body. Agents appear to act by rendering the organism more susceptible to infections. The resistance power will be diminished. The spe culation therefore arises whether occupationally exposed workers are more vulnerable to common infections than subjects not ex posed to poisonous substances, but clear evidence to prove this suggestion is still absent. The influence on the immunitary de fence may be an important aspect of the assessment of toxicity. In a series of papers Fonzi et al reported the noxious effect of lead upon the defensive power of the animal body 5^5--J58 . These studies revealed that lead-treated animals, subsequently sub jected to active immunization, showed lower antibody globulin contents (V-fraction) than unexposed animals. The normal "com plement" of the blood serum, residing in the globulin fractions appeared to be progressively reduced, whereas the amount of anti typhoid antibodies in the serum of lead-affected animals showed a relative deficiency after specific vaccination, as compared with normal animals (rabbits). There is every likelihood that lead interferes with either the synthesis of some antibody pro teins or alternatively impairs the functioning of these proteins by formation of inactive metallo-protein complexes, thereby af fecting the antibody protein balance in the blood. The problem arises whether this may precede the development of toxic mani festations or coincides with a later stage of the poisoning. One of the elements in the defense mechanism is lysozyme. This is a polypeptide, capable to bring on lyses of certain bacterial strains and present in body fluids and organs. Lysozyme activity appeared to be progressively reduced in the organs (spleen) and serum of dogs, chronically poisoned with lead salts59 . The mean serum lysozyme activity was below normal in a group of workers, showing obvious signs of lead poisoning; the lowest values were obtained in the severest affected cases. So far, none data on the altered immunologic response has been obtained in people working in non-hazardous circumstances of industrial work. DUP050313171 - 30 - The phenomena above outlined may be brought into relation with the behaviour of the vitamin C level of the adrenal glands in case of human lead absorption. It is known that the metal exerts a depriving effect on the vitamin C content of this or gan^. Furthermore loss of vitamin C from the cortex is asso ciated with increased viability of the body against infection. j. blood mucopolysaccharides These substances occur in the tissues as prosthetic groups of conjugated proteins (muco- or glycoproteins). In the plasma they form a part of the and o^-globulin fractions. The sialic acids, compounds derived from neuraminic acid, are also important constituents of the polysaccharide moiety of these mucoproteins (serum mucoids). In clinical medicine, some value has been a- scribed to the determination of the sialic acids in respect to the' diagnosis and early detection of several diseases (acute rheumatic fever). As constitutive part of the glycoproteins, it is increased in various inflammatory processes and also in sili cosis. Serum mucoid and sialic acid determinations extended to the field of lead toxicology gave os result that these contents were below normal in 124 patients with slight to moderate poiso- nous symptoms . Sialic acid in blood serum was also lowered in dogs with experimental poisoning. Serum neuraminic acid was shown to be consistently decreased both in lead-treated rats and in workers, even in the absence of apparent toxic signs. From the latter observation, it is suggested that the assay of the acid may be a poisoning index of exposure degree 62 . Further re search is necessary to reveal possible correlations with other blood parameters, indicative for exposure. k. abnormal hemoglobins The presence of abnormal fetal type of hemoglobin, denoted as HbF, could be demonstrated in advanced stages of lead poisoning. Won-elevated levels or contents slightly above those of unexposed individuals were encountered in cases of mild poisoning or heavy exposure63 ' 64 . From the data, it is concluded that HbF produc tion is a biochemical event, which does not precede pathologic DUP050313172 - 31 signs of lead toxicity. In experiments on animals, it was found that there exists a distinct correlation between the HbF level and both the degree of basophilia or the erythrocyte count ,, This suggests that the HbF content, as determined by electropho resis, might have some significance in evaluating the degree of poisoning. 5-Bydroxyindole acetic acid (5-HIAA) The level of this compound is shown to be in elevated concen trations in the urine in 227 children, inhabiting an air-polluted 65 area in the vicinity of lead-processing industries . Ghelberg et al ascertained that there exists a well-defined relationship between the proportion of cases with increased 5-HIAA-excretion and the mean concentration of lead in the ambient air. So far, no reports have appeared on the excretory output of the compound in lead workers. The finding above mentioned, infers that the assay of 5-HIAA might be a useful index of exposure degree and intensity . In view of the fact that 5-HIAA is the final meta bolite of a minor pathway of the tryptophan breakdown, it is sug gested that lead interferes in some manner with the enzymatic degradation of tryptophan. It has been put forward that the as sociation between vitamin Bg (pyridoxal phosphate) deficiency and lead poisoning lies at the basis of the impaired tryptophan metabolism. Pyridoxal phosphate functions as a coenzyme for en zymatic conversions in the major pathway of the catabolism of tryptophan. The state of vitamine Bg-defieiency, evoked by lead, should lead to a suppression of this main pathway - due to en zymatic inhibition - which in turn favors the conversion of tryptophan along the minor path leading to 5-HIAA. Some evidence is presented that lead actually operates in this way as is evi- 66 dent from the increased excretion of xanthurenic acid ,, Vita min Bg administration resulted in a drop of the urinary output of this metabolite. A systematic analysis of the various inter mediates and excretory products involved in the tryptophan meta bolism (5-HIAA, kynurenic acid, xanthurenic acid, nicotinic acid) following lead intake, however, seems to be necessary to in vestigate this action more profoundly. DUP050313173 - 32 - m. effect of lead on nicotinic acid 67 Caccuri drew attention to a distinct relationship between lead poisoning and the metabolism of nicotinic acid. Lead poison ed animals exhibit a pronounced decrease of nicotinic acid in blood and urine. This fact, together with the observations made after the administration of the vitamin following lead salt in take, has forced these authors to assume that in metal poisoning utilization of nicotinic acid is greatly increased with consequently a reduction of coenzymes I and II (NAD, NADP) . It is suggested that lead severely affects the pyridine nucleotides, either by blocking the synthesis of these substances or by en hancing the degradation of nicotinic acid. Another manifestation of this action is the altered nucleic acid content (1NA, DNA) of leucocytes, neutrophils and monocytes detected in patients with 69 plumbism. Nunziante Cesaro and Granata evaluated the concen tration of these substances quantitatively by means of an inge- nous cytophotometrical method in blood smears, and claimed that the method should be practically applied as a test to assess the severity of lead poisoning. The interference of lead in vivo with the nucleotide metabo lism and the disorders on porphyrin level evoked by the metal, seem to be related in some way. Actually, blood and urine nico tinic acid decrease, at the same time as CP III is steadily in creasing. Prophylactic administration of nicotinic acid or the amide prevent the development of porphyrinuria, induced by lead intake. The anemic signs of lead intoxication could be partly reversed by administration of inosine, AMP, constitutive parts of the 70 nucleotides ' 71 1 72 . These substances also maintain the urinary output of lead, 5-ALA and CP within the normal range. Apart from the interesting objective to elucidate more extensive ly the toxic mode of action on necleotide-level, studies should be focused on the possible interrelationship between nicotinic acid levels in blood and urine and the other body fluid indices, like CP, 5-ALA a.s.o., in case of non-hazardous lead absorption. DUP050313174 - 33 - Bibliography 1* WaldmanR.K.; Borman E.K. A.M.A.Arch.Ind.Hlth 190959)431 2. Brigatti L. ; Parigi A.; Varetto L. Med.Sociale 53(1962)1268 3. Hanke J.Z. Arch.Hig.Rada Toksikol. 15(1964)57 4- Casula D..; Cherchi P.; Piredda S.; Spinazzola A. Bass.Med. Sarda 6l(1959)839 5. Balbo W.; Marucci V. Zacchia 25(1962)419 6. Corsi G.C. ; Galzigna L. Lav.Umano 15(1963)364 7. Waldron H.A. J.Clin.Pathol. 17( 1964:) 14'9 8. Minden H.; Zegarski W.; Rothe R. Arch.Gew.Pathol. .Gew.Hyg. 20(1964)461 9. Yaverbaum P.M. Gig.Truda " Prof.Tabol. 7,0963)38 10. Kosmider S. Arch.Gew.Pathol. .Gew.Hyg. 20(1963)11 11. Kosmider S. Pol.Arch.Med.Wewnet 32(1963)1253 12. Soldatovic D.; Petrovic C. Archiv.Farm. 13(1963)253 13. Batolska A. From Abstr.Bulgar.Sci.Lit. Med.Phys.Cult. 6(1963)32 14. Passow H.; Rothstein A.; Clarkson T.W. Pharmacol.Rev. 23(1961)185 15. Hasan J.; Vihko V.; Hernberg S. Arch.Env.Hlth 14(1967)313 16. Hernberg S.; Vihko V.; Hasan J.' Arch.Env.Hlth 14(1967)319 17. Jonek J.; Kosmider S.; Grzybek H. Arch.Immunol.Ther.Exp. 21(1963)652 18. Jonek J.; Jonek J.; Kosmider S. Med.Pracy 16(1965)211 19. Sroczynski K.; Zajusz K. Arch.Immunol.Ther.Exp. 14(1966)391 20. Camba R.; Dianzani Mor M.A.; Montaldo S. Rass.Med.Sarda 24(1963)591 21. Makasher K.K.; Verbolovich V.P. Izv.Akad.Nauk.Kaz.SSR, Ser.Biol. j5(1967)59 22. Granati A. Folia Med. 39(1956)853 DUP050313175 - 34 - 23 = Cervetti S.$ Casucoi G. Lav.Umaao 12( 1960)452 24. Kolkovski P.; Rajceva V. Arch. Yoxik. 19(1961)237 25* Ambrosio L. Folia Med. 43(1962)404 260 Plamieniak Z.; Smolik H. Polski Tygod.Lek. 18(1963)338 27. Gelfon L.A. From: Bef;Zh, Khim 1964 Abstract No.6 I 254 28. Gelfon I.A.; Zorina L.A. Gig.Trud. Prof.Zabol 8(1964)24 29= Kosmider S.; PotTika Z. 170 Zentr.bl. Arb.Med. Arb.Sch. 17(1967) 30. Sroczynski J.; Piekarski B. Post.Hig.Med.Doswiadc. 13(1959) 781 31. Afonova V.N. Sb.Nauchn.Tr., Ryazansk.Med.Inst. 12(1960)129 32. Bahyrycz M.; Kujavrska A.; Spett K. Med.Pracy 13(1962)429 33 Singerman A. Arch.Env.Hlth .9(1964)464 /"j.E. 34. Clarkson T.W.; Kench/-Bioch.J. 62(1956)361 35 Studnitz W.; Haeger Aronssen B. Act.Pharm.Tox. 19(1962)36 36. Sun G.N. ; Goyer R.A.; Mellies M.; Tin M.W. 82(1965)156 Arch.Pathol. 37. Eossi A.5 Fondacaro S. Folia Med. 45(1962)1281 38. Aldanazarov A.T.*, Dukravets N.A.; Baram M.G. 5 Tr.Kazakhsk Akad.Med.Nauk.SSE 14(1965)93 39. Eubino G.F.; Pagliardi E.; Prato V; Giangradi E. Brit.J. Haematol. 4(1958)103 40. Kosmider S.; Grabski J.; Stradowski J. Arch.Imm.Ther.Exptl. 11(1963)303 41. Soldatovic D.5 Bresjanac M.; Petrovic C. Arh.Farm. 15(1965)1 42. Kumagai A.; Sakai T. Arch.Int.Pharmacodyn Ther. 160(1966)248 43. Cantarow A.5 Trumper M. Lead poisoning (1944) 44. Kanner N,,L. Terapevt. Arkh 35(1963)95 45. Kanner N.L. Probl.Endokr. Gormonoter 11(1965)82 DUP050313176 35 - 46. Sandstead H.H.; Galloway R. Proc.Soc.Exptl. Biol.Med. 124(1967)18 47. Soldatovic D.; Djurovic M. ; Petrovic C. Arh.Farm. 16(1966)151 48. Cataldi R. 5 Odaglia G. Xllth Int.Congr.Occup.Hlth 1957, Helsinki p.56 49. Saita G. Med.Lav. 510960)694 50. Bruno G.F.; Coscia G.C.; Perrelli G.; Parigi A. Minerva Med. 40963)930 51. Bonsignore D.; Cartasegna C.; Ardoino V.; Vergnano C. Lav.Umano 19(1967)97 52. Rogulski J.; Senczuk .5 Zegarski W. 1966 se:Chem.Abstr.No.l65l8 53. Afonora V.M.j Moshchenko A.I. Sb.Nauchr.Tr.Ryazansk.Med. Inst. 15(1962)3 54. Ghelberg N.W.; Bretter E.; Costin L. ; Chitul E. Igiena (Buc.) 15(1966)209 55. Fonzi S.; Peugue L.; Raddi E. Lav.Umano 190967)123 56. Fonzi S.; Pengue L.; Raddi E. Lav.Umano 19(1967)200 57. Fonzi S.; Pengue L. Lav.Umano 190 967)282 58. Fonzi S.; Pengue L.; Raddi R. Lav.Umano 19(1967)324 59. Ambrosio L.; Mazza V. Riv.Ist.Sieroterap.Ital. 290954)252 60. Gontzea I.5 Sutescu P.; Stanciu V.5 Lungu D. Igiena (Buc.) 15(1964)501 61. Aitbaev T.Kh.; Aldanazarov A.T.; Beglova T.G. From: Ref.Zh.Farm.Toks. 1964, Abstr.No.7, 54276 62. Camerada P.5 Congiu M.; Leo P. Rase.Med.Sarda 66(1964)253 63. Buc^kowski M,, Arch.Gew.Path.Gew.Hyg.20(1964)537 64. Dulong de Roseney Ch. 5 Labadie P.; Debot P.5 Arch.Mai.Prof. 180957)425 65. Ghelberg N.W.5 Gorgan I.; Checiu Igiena (Buc.) 15(1966)87 66. Fati S. Biochim. Appl. _8(l96l)28o DUP050313177 - 36 - 67 Caccuri S. Folia Med. 26(1940)345 68<> Silvestroni P.; Balletta A. Biochiro.Appl. 11 (1964)250 ;69 Nunziante Cesaro A.; Granata A. Arch.Mai.Prof. 18(1957)412 ;.70. Gajdos'A.; Gajdos-Torok M.; Danieli G. Rev.Fr.d'Etud.Clin, et Biol. 9(1961)888 ' 71.- Gajdos A.; Gajdos-Torok M.; Danchev D.; Benard H. New.Rev. Franc. Hematol. ki 1964)383 'fy\. ' 72. Bilski-Pasquier G. j Bondene C.5 Gajdos A. Preese Med. 73 ; (1965)2741. ) DUP050313178 - 37 - fOMMABY Observations of the effects of lead in living matter have effec tively manifested a variety of hematological and biochemical pa rameters. A summary of these effects is presented in the table below. Observed indices URINE lead coproporphyrine (type I and III) 5-aminolevulinic acid aminoacetone alanine glycine steroids 5-hydroxyindoleacetic acid tryptophan metabolites nicotinic acid iron BLOOD (whole blood or erythrocytes) lead hemoglobine hemoglobine F red blood cell count Heinz bodies free protoporphyrine IX (ery's) number reticulocytes basophilic count siderocytes osmotic resistance (red cells) survival time (red cells) uptake of radiophosphorous (red cell membrane) glucose consumption (Na+ + K+) ATP-ase catalase carbonic enhydrase Response to lead 4* + 4. + 44 44 + 4- - and + in advanced poisoning 44 (?) ++ ++ 4- 44 44 44 44 44 4 4* DUP050313179 - 38 - Observed indices Besponse to lead 5-aminolevulinic dehydratase hem esynthe t as e UPG-decarboxylase nucleic acids (DWA, BNA) in leucocytes, neutrophils and monocytes pyridine-nucleitides (HAD, NADP) (erythrocytes) free thiol groups glutathione nicotinic acid K+-loss (ery's) copper (ery's) SEBUM or PLASMA 5-aminolevulinic acid aminoacetone sine copper calcium potassium iron iron-binding capacity serum proteins (Alb/Glob ratio) otg and P globuline Y-globuline cc-aminonitrogen prothrombine thromboplastic factors (VII) complement antibody globuline (Y) after immuni zation antityphoid antibodies lysozyme neuraminic acid ., seromucoid l mucopolysaccharides sialic acid ! protein bound iodine (PB I) (-) + and - alterations (- -) 4 4* + ++ (+) or (+ +) 4 4 + 44 4 4 4 - or - - (-) DUP050313180 Observed indices transaminases (SGOT, SGPT) aldolase alkaline phosphotase pseudo cholinesterase Response to lead + ++ - + (+) or (-) 4- + or - - increase or intensification decrease in or retardation response not quite certain early response, preceding the appearance of clinical signs of toxicity DUP0503131 81